Payers, Providers, And Patients Could All Feel Potential Tariff

Payers, Providers, And Patients Could All Feel Potential Tariff

Update (5/30/18): The White House has indicated it will place a 25% tariff on $50 billion of Chinese goods. The Trump Administration plans to finalize this list by June 15. By the end of that month, the administration will also announce investment restrictions and “enhanced export controls” for Chinese individuals and entities “related to the acquisition of industrially significant technology.” For more information, please see the White House’s announcement.

Update (5/21/18): The White House has announced a temporary agreement with China on trade. The announcement comes after HIDA members reached out to their representatives on the impact potential tariffs would have on their businesses, and after HIDA testified before the U.S. Trade Representative Committee on Section 301.

Tariffs proposed by the Trump Administration in April could have a real effect on anyone who delivers or receives care. The list of products imported from China that could face an additional duty of 25% is long, and includes products used in all kinds of medical care. These include:

  • Syringes and needles
  • Sterile surgical catgut, suture materials, tissue adhesives for wound closure
  • MRI machines
  • Defibrillators
  • Artificial joints
  • Pacemakers
  • Dental equipment, such as drills and burs

HIDA’s Government Affairs team is in the process of gathering information from members in order to craft an industry response. In the meantime, you can check out the government’s request for public comment. And if you think these tariffs will affect you, be sure to contact your state and federal representatives.

If you would like to learn more about the tariffs and their potential impact, please contact

Posted in: Advocacy and Gov Affairs, Cost Management, HIDA News, How distributors make a difference, Policy Outlook & Analysis

Leave a Comment (0) →